Atlas Trials

Comparison of the Efficacy of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Norfloxacin in Secondary Prophylaxis for Spontaneous Bacterial Peritonitis

Clinical trial NCT03702426 · COMPLETED

Trial details

NCT number
NCT03702426
Sponsor
Institute of Liver and Biliary Sciences, India
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Spontaneous Bacterial Peritonitis
Start date
2018-07-23
Primary completion
2019-07-31
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.